Patent assignee · US · COMPANY

Gilead Calistoga LLC

16Patents
16Active
16Granted
48Portfolio score

Filing activity: Mar 24, 2010 → Nov 17, 2017 · 3 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8865730B2 Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one Chemistry; Metallurgy 17 Active
US8691829B2 Treatment of liver disorders with PI3K inhibitors Human Necessities 12 Active
US9708327B2 Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one Human Necessities 11 Active
US9029384B2 Phosphatidylinositol 3-kinase inhibitors Chemistry; Metallurgy 9 Active
US9469643B2 Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one Chemistry; Metallurgy 7 Active
US10047060B2 Process methods for phosphatidylinositol 3-kinase inhibitors Chemistry; Metallurgy 7 Active
US10059677B2 Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereof Chemistry; Metallurgy 7 Active
US9266878B2 Phosphatidylinositol 3-kinase inhibitors Chemistry; Metallurgy 7 Active
US8440677B2 Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use Human Necessities 4 Active
US9018221B2 Phosphatidylinositol 3-kinase inhibitors Chemistry; Metallurgy 3 Active
US10442805B2 Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one Human Necessities 3 Active
US9238070B2 Therapies for hematologic malignancies Human Necessities 2 Active
US10730879B2 Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one Chemistry; Metallurgy 2 Active
US9492449B2 Therapies for hematologic malignancies Human Necessities 1 Active
US10154998B2 Therapies for hematologic malignancies Human Necessities 0 Active
US8546409B2 Methods of treatment for solid tumors Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.